Second-Line VWD Testing: Characterization, Not Confirmation

Prev
 1 / 20 
Next
Prev
 1 / 20 
Next

Learning objectives

After completing this quiz, the learner should be able to:

  • recognize second-line VWD testing as mechanism localization rather than indiscriminate confirmation
  • interpret first-line VWF, FVIII, and platelet patterns to generate targeted diagnostic questions
  • distinguish quantitative VWF deficiency from qualitative VWF dysfunction using relational laboratory patterns
  • apply activity-to-antigen ratios to decide when additional type 2 characterization is needed
  • identify when multimer analysis, VWF, RIPA, VWF, VWFpp, DDAVP response, or genetic testing is most useful
  • avoid common pitfalls related to over-testing, preanalytic artifact, and premature subtype assignment
  • integrate clinical context, bleeding phenotype, family history, and laboratory patterns when interpreting second-line results

What is the central thesis of the essay?

a
Second-line VWD tests should be ordered whenever VWF antigen is low
A is incorrect because mildly low VWF antigen alone does not automatically justify broad second-line testing.
b
Second-line VWD tests are primarily used to prove that VWD is present
B is incorrect because second-line tests may confirm a mechanism or subtype, but they do not establish the whole diagnosis in isolation.
c
Second-line VWD tests should be selected to answer specific mechanistic questions
C is correct because the essay argues that second-line testing is best understood as characterization and localization. These assays should follow a first-line pattern and answer a defined question about mechanism, subtype, or boundary adjudication. The reasoning principle is pattern → question → targeted test.
d
Second-line VWD tests are more reliable than bleeding history
D is incorrect because the essay repeatedly emphasizes that second-line tests do not replace bleeding history or clinical judgment.

A patient has low VWF antigen and low platelet-dependent VWF activity that are reduced proportionally. There is a mild bleeding history and no other discordant findings. What is the best next diagnostic principle?

a
Order multimer analysis, RIPA, VWF, and genetic testing immediately
A is incorrect because ordering everything violates the essay’s central warning against testing by accumulation.
b
Treat the pattern as most consistent with quantitative deficiency and consider repeat testing before advanced assays
B is correct because proportional reduction of VWF antigen and activity usually points toward quantitative deficiency rather than a qualitative defect. In an otherwise typical mild type 1 or low VWF pattern, repeat testing and assessment of clinical context may be more useful than immediate advanced testing. The reasoning principle is do not escalate until the pattern creates a question.
c
Diagnose type 2B VWD because activity is low
C is incorrect because type 2B requires suspicion of enhanced platelet binding, often with disproportionate activity loss, multimer abnormalities, thrombocytopenia, or relevant genetic/RIPA findings.
d
Diagnose type 2N VWD because VWF is reduced
D is incorrect because type 2N is suggested by disproportionately low FVIII, not simply low VWF.

What does a low platelet-dependent VWF activity/VWF antigen ratio most directly suggest?

a
A qualitative VWF defect may be present
A is correct because a low activity-to-antigen ratio suggests that the amount of VWF protein does not fully explain the functional abnormality. The protein may be present but qualitatively impaired, prompting consideration of type 2 characterization. The reasoning principle is relationships among values matter more than isolated values.
b
Type 3 VWD is confirmed
B is incorrect because type 3 VWD involves virtually absent VWF and cannot be diagnosed from a low ratio alone.
c
Bleeding severity is high
C is incorrect because the ratio does not directly measure clinical bleeding severity.
d
FVIII binding is normal
D is incorrect because FVIII binding requires separate assessment when FVIII is disproportionately low.

Why does assay choice matter when interpreting platelet-dependent VWF activity?

a
All VWF activity assays are physiologic and interchangeable
A is incorrect because the essay explicitly states that no assay is fully physiologic and methods are not identical.
b
VWF can be affected by variability, low-level sensitivity, and ristocetin-related artifacts
B is correct because the essay notes that VWF is historically important but imperfect. It uses ristocetin, which is nonphysiologic, and may yield misleadingly low results in some individuals because of ristocetin-binding effects rather than true physiologic dysfunction. The reasoning principle is second-line testing is only as good as the first-line pattern that triggers it.
c
VWF and VWF eliminate the need for clinical interpretation
C is incorrect because newer assays may be preferred when available, but they still require laboratory expertise and clinical interpretation.
d
VWF activity assays replace VWF antigen testing
D is incorrect because VWF antigen remains part of the first-line relationship that allows ratios and patterns to be interpreted.

A patient has a low VWF activity/VWF antigen ratio. Multimer analysis shows loss of high-molecular-weight multimers. Which boundary is most relevant?

a
Type 1 VWD versus low VWF
A is incorrect because type 1 and low VWF usually involve proportional quantitative reduction rather than selective loss of high-molecular-weight multimers.
b
Type 2A VWD versus type 2B VWD or acquired VWF dysfunction
B is correct because loss of high-molecular-weight multimers localizes the problem to VWF architecture or survival of large multimers. This can support type 2A or type 2B VWD, and in the right clinical context may also raise acquired von Willebrand syndrome. The reasoning principle is second-line testing adjudicates boundaries between adjacent mechanisms.
c
Type 2N VWD versus mild hemophilia A
C is incorrect because type 2N is suggested by disproportionate FVIII reduction and requires FVIII-binding evaluation or genetics.
d
Type 3 VWD versus normal variation
D is incorrect because type 3 VWD involves virtually absent VWF, not simply loss of high-molecular-weight multimers.

What is the main value of VWF collagen-binding testing in the essay?

a
It replaces bleeding history
A is incorrect because no second-line assay replaces the bleeding phenotype.
b
It confirms VWD in all borderline cases
B is incorrect because VWF may support a mechanism or subtype but does not establish the whole diagnosis alone.
c
It can help assess collagen-binding function and may serve as a clue to high-molecular-weight multimer loss
C is correct because VWF asks whether VWF can bind collagen appropriately, depending on assay design and collagen source. Since collagen binding is influenced by multimer size, VWF/VWF may also help identify loss of high-molecular-weight multimers. The reasoning principle is one assay may answer a related but distinct localization question.
d
It is useful only for type 3 VWD
D is incorrect because VWF is particularly relevant in qualitative VWD assessment, especially suspected type 2 patterns.

A patient has a low activity-to-antigen ratio, loss of high-molecular-weight multimers, and intermittent thrombocytopenia. Which diagnostic question is most appropriate?

a
Is this type 2B VWD or platelet-type VWD
A is correct because the combination of qualitative VWF dysfunction, loss of high-molecular-weight multimers, and thrombocytopenia raises concern for enhanced VWF–platelet interaction. The key boundary is type 2B VWD, where the problem is usually in VWF, versus platelet-type VWD, where the problem is usually in platelet GPIb. The reasoning principle is similar phenotypes can reflect different biologic locations.
b
Is this type 2N VWD or hemophilia A
B is incorrect because type 2N is driven by defective FVIII binding and disproportionate FVIII reduction.
c
Is this low VWF or normal variation
C is incorrect because the pattern is not a simple borderline quantitative pattern.
d
Is this isolated FVIII deficiency
D is incorrect because the platelet count and VWF activity pattern point toward the VWF–platelet axis rather than isolated FVIII deficiency.

In suspected type 2B VWD, how should RIPA be framed according to the essay?

a
It is obsolete and should never be discussed
A is incorrect because RIPA remains clinically and conceptually relevant.
b
It is conceptually central but increasingly paired with or replaced by targeted genetic testing when available
B is correct because RIPA remains important for understanding enhanced VWF–platelet interaction, especially low-dose platelet agglutination. However, the essay notes that modern guidelines may favor targeted genetic testing over low-dose RIPA for suspected type 2B when additional testing is needed and genetic testing is available. The reasoning principle is historical and mechanistic importance does not always equal preferred operational pathway.
c
It confirms type 1 VWD
C is incorrect because type 1 VWD is a quantitative deficiency and is not confirmed by RIPA.
d
It is a routine screen for every patient with suspected VWD
D is incorrect because RIPA should be ordered only when the VWF–platelet interaction is the diagnostic question.

A patient has FVIII that is much lower than expected for the VWF antigen and platelet-dependent activity levels. What is the best second-line question?

a
Is there defective VWF-mediated FVIII carriage versus primary FVIII deficiency
A is correct because disproportionate FVIII reduction raises the classic boundary between type 2N VWD and mild hemophilia A. VWF testing and/or targeted genetic testing can help determine whether the problem is VWF-mediated FVIII carriage or primary FVIII deficiency. The reasoning principle is a discordant first-line relationship should generate a specific localization question.
b
Is there increased VWF collagen binding
B is incorrect because collagen binding does not address the central FVIII carriage question.
c
Is the platelet count falsely elevated
C is incorrect because the platelet count is not the key abnormality in this pattern.
d
Is this automatically type 2B VWD
D is incorrect because type 2B involves enhanced platelet binding, not defective FVIII carriage.

Which scenario best illustrates the “preanalytic trap” described in the essay?

a
A patient has repeatedly low VWF values collected at baseline health and concordant bleeding history
A is incorrect because repeated baseline testing strengthens rather than weakens the pattern.
b
A patient with suspected type 2N undergoes VWF testing
B is incorrect because VWF is appropriate when FVIII is disproportionately low and type 2N is suspected.
c
A patient with thrombocytopenia and low-dose RIPA positivity undergoes genetic testing
C is incorrect because genetic testing can be appropriate when type 2B or platelet-type VWD is in the differential.
d
A patient has borderline VWF results drawn during acute inflammation and is sent for extensive subtype testing without repeat baseline testing
D is correct because VWF levels can be affected by stress, inflammation, pregnancy, acute bleeding, exercise, aging, and sample handling. The essay emphasizes that second-line testing cannot rescue a poorly defined or poorly collected first-line pattern. The reasoning principle is validate the pattern before localizing the mechanism.

What does the essay mean by “boundary adjudication”?

a
Using second-line tests to decide between adjacent diagnostic possibilities with overlapping phenotypes
A is correct because the essay frames second-line testing as a way to clarify boundaries such as type 2A versus type 2B, type 2B versus platelet-type VWD, type 2N versus mild hemophilia A, and inherited VWD versus acquired von Willebrand syndrome. The reasoning principle is localization helps determine which side of a diagnostic boundary the patient is likely to occupy.
b
Using second-line tests to replace classification
B is incorrect because second-line testing supports classification rather than replacing it.
c
Using genetic testing to diagnose all VWD subtypes
C is incorrect because genetic testing is useful in selected forks but is not a universal diagnostic shortcut.
d
Using a single cutoff to eliminate uncertainty
D is incorrect because the essay emphasizes that continuous biology and assay variability often prevent simple cutoff-based certainty.

Sort each item into one of three buckets.

Disproportionately low FVIII:C
Assuming VWF:Ag confirms VWD:CB by itself
Mild thrombocytopenia with qualitative VWF pattern
Ordering every assay after one abnormal value
Targeted genetic testing
Low platelet-dependent VWF activity/VWF antigen ratio
Treating RIPA as a routine screen for all suspected VWD
Multimer analysis
Interpreting a stress-influenced VWF result as definitive
Proportional reduction in VWF antigen and activity
Using a normal aPTT to exclude VWD
Ignoring acquired von Willebrand syndrome in an older patient
VWFpp/VWF:Ag
VWF:Ag/VWF:Co
Low-dose RIPA
First-line pattern
Second-line localization tool
Diagnostic pitfall or caution

Match the concept with the best description.

VWF:FVIIIB
VWF:CB/VWF:Ag
Low-dose RIPA
Helps distinguish defective VWF-mediated FVIII carriage from primary FVIII deficiency.
Helps identify enhanced VWF–platelet interaction when type 2B VWD or platelet-type VWD is suspected.
Helps assess collagen-binding function and may provide a clue to loss of high-molecular-weight multimers.
Correct! Sorry, Incorrect.

Closing Note

VWD diagnosis begins with a question, not a panel.

Where is the bleeding coming from? Primary hemostasis, secondary hemostasis, vascular integrity, or some combination of these? Only after that localization does a VWF result acquire meaning.

The danger is premature closure. A low number can be overread. A normal screening panel can be falsely reassuring. A borderline VWF level can become a lifelong label, or a real bleeding phenotype can be dismissed as normal variation.

Good diagnosis holds the phenotype, the laboratory pattern, and the context together. It asks whether the findings form a coherent mechanism before naming disease.

The goal is not to prove VWD.

The goal is to understand the bleeding.

Prev
 1 / 20 
Next